![Dr. Russell J Schilder M.D., Doctor](/fatd/images/avatar.png)
Dr. Russell J Schilder M.D.
Oncologist | Medical Oncology
925 Chestnut St Suite 320a Philadelphia PA, 19107About
Dr. Russell Schilder is an oncologist practicing in Philadelphia, PA. Dr. Schilder specializes in the care and treatment of patients with cancer. As an oncologist, Dr. Schilder manages and oversees the treatment of a cancer patient after he or she has been diagnosed with the disease. Oncologists will care for their patients throughout the course of the disease. Types of oncologists include medical oncologists, surgical oncologists, radiation oncologists, gynecologic oncologists, pediatric oncologists and hematologist oncologists.
Education and Training
Univ of Miami Sch of Med, Miami Fl 1983
University of Miami Leonard M. Miller School of Medicine 1983
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Hematology
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Radioimmunotherapy of relapsed non-Hodgkin's lymphoma with zevalin, a 90Y-labeled anti-CD20 monoclonal antibody.
- Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphoma.
- Population pharmacokinetic and limited sampling models for carboplatin administered in high-dose combination regimens with peripheral blood stem cell support.
- Pilot evaluation of high-dose carboplatin and paclitaxel followed by high-dose melphalan supported by peripheral blood stem cells in previously untreated advanced ovarian cancer: a gynecologic oncology group study.
- Gynecological malignancies.
- Focus on epithelial ovarian cancer.
- Safety and efficacy of radioimmunotherapy with yttrium 90 ibritumomab tiuxetan (Zevalin).
- Management of early-stage ovarian cancer.
- Durable responses after ibritumomab tiuxetan radioimmunotherapy for CD20+ B-cell lymphoma: long-term follow-up of a phase 1/2 study.
- Factors associated with toxicity and response to yttrium 90-labeled ibritumomab tiuxetan in patients with indolent non-Hodgkin's lymphoma.
- Evaluation of gemcitabine in previously treated patients with non-squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
- Imatinib mesylate and its potential implications for gynecologic cancers.
- Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma.
- Novel non-cytotoxic therapy in ovarian cancer: current status and future prospects.
- Relevant molecular markers and targets.
Treatments
- Breast Cancer
- Ovarian Cancer
- Wrinkle & Scar Improvement
Dr. Russell J Schilder M.D.'s Practice location
Practice At 333 Cottman Ave Fox Chase Cancer Center
333 Cottman Ave Fox Chase Cancer Cen -Philadelphia, PA 19111Get Direction
Practice At 925 Chestnut St Suite 320a
925 Chestnut St Suite 320a -Philadelphia, PA 19107Get Direction
Dr. Russell J Schilder M.D.'s reviews
Write ReviewRecommended Articles
- What Impact Does Hospital Volume Have on Ovarian Cancer Survival?
Ovarian cancer is one of the most difficult cancers to treat. Though overall survival is generally over 90% if caught early, only about 15% of ovarian cancers are diagnosed at early stages. This means that many women are diagnosed with ovarian cancer at more advanced stages with high mortality.With...
- How Ovarian Cancer 'Previvors' Are Paving the Way
Nancy Crowe is a previvor, but she understands if someone doesn’t know what that means. It’s a relatively new term which arose in 2000 from a challenge posted on FORCE’s website. FORCE stands for Facing Our Risk of Cancer Empowered and was started by Sue Friedman in 1999.Sue says the goal of...
- Is Ovarian Cancer Terminal?
Let’s answer the question first: It depends on the stage of the disease. There are four stages of ovarian cancer, and the third and fourth are the most dangerous. The bad thing is that most cases of ovarian cancer are diagnosed in the later stages of the disease, when little can be done to save...
- Holistic Treatments for Liver Cancer
Holistic treatment for liver cancer indicates a science of healing that uses the person's whole spirit, mind and body. This treatment practice integrates the alternative and conventional therapies used to prevent and treat liver cancer, as well as promote the patient's wellbeing. The principle...
- What is Cancer Immunotherapy?
Immunotherapy, also referred as biological therapy, is a special type of cancer treatment aimed at boosting the body's immune system to help fight cancer cells. Cancer cells don’t die normally as other cells do, and divide uncontrollably with each cell making more of itself like a copy machine...
- Why This Lymphoma Patient Has A New Lease on Life
59-year-old Judy Wilkins, a mother of two and owner of a hair salon, had been battling lymphoma for years. The cancer became so aggressive that she tried four different chemotherapy regimens over a course of 18 months, with an aim to put it into remission. Nothing worked until CAR T-cell therapy....
Nearby Providers
- Dr. John Sprandio, Sr. MD800 Spruce St Philadelphia PA 19107
- Dr. Sanaa Rizk MD1015 Chestnut St Philadelphia PA 19107
- Dr. Jon Glass MD909 Walnut St Philadelphia PA 19107
- Dr. Ana Maria Lopez MD925 Chestnut St Philadelphia PA 19107
- Dr. Edith Mitchell M.D.925 Chestnut St Philadelphia PA 19107
- Dr. Christopher Edward Fundakowski M.D.925 CHESTNUT ST FL 6 PHILADELPHIA PA 19107
Nearest Hospitals
NAZARETH HOSPITALl
2601 HOLME AVE PHILADELPHIA PA 19152CANCER TREATMENT CENTERS OF AMERICAl
1331 EAST WYOMING AVENUE PHILADELPHIA PA 19124THOMAS JEFFERSON UNIVERSITY HOSPITALl
111 SOUTH 11TH STREET PHILADELPHIA PA 19107PENNSYLVANIA HOSPITALl
800 SPRUCE STREET PHILADELPHIA PA 19107HAHNEMANN UNIVERSITY HOSPITALl
230 NORTH BROAD STREET PHILADELPHIA PA 19102